Latest Articles
- EditorialSecondary progression and innate immunity in NMOA possible link to alemtuzumab therapy?Kazuo Fujihara, Ichiro NakashimaOctober 09, 2014
- ArticleCCR2 on CD14+CD16+ monocytes is a biomarker of HIV-associated neurocognitive disordersDionna W. Williams, Desiree Byrd, Leah H. Rubin, et al.October 09, 2014
- ArticleMassive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMOJeffrey M. Gelfand, Jennifer Cotter, Jeffrey Klingman, et al.October 09, 2014
- ArticleAccumulation and therapeutic modulation of 6-sulfo LacNAc+ dendritic cells in multiple sclerosisKatja Thomas, Kristin Dietze, Rebekka Wehner, et al.September 18, 2014
- Clinical/Scientific NotesHyperacusis as the initial presentation of Creutzfeldt-Jakob diseaseAlexander E. Merkler, Mukesh Prasad, Ehud Lavi, et al.September 18, 2014
- ArticleIV immunoglobulin confounds JC virus antibody serostatus determinationIlya Kister, Geoffrey Kuesters, Eric Chamot, et al.September 18, 2014
- Clinical/Scientific NotesTransient neonatal autoimmune autonomic ganglionopathySteven K. Baker, Beverley M. Chow, Steven A. VerninoSeptember 18, 2014
- Clinical/Scientific NotesAvidity of vaccine-induced influenza IgG fails to increase in fingolimod-treated patients with MSMatthias Mehling, Dominik Eichin, Patricia Hafner, et al.September 11, 2014
- Clinical/Scientific NotesEarly cervical myelitis after human papilloma virus vaccinationMireya Fernández-Fournier, Javier Díaz de Terán, Antonio Tallón Barranco, et al.September 11, 2014
- ArticleHCV, but not HIV, is a risk factor for cerebral small vessel diseaseSusan Morgello, Jacinta Murray, Sarah Van Der Elst, et al.September 04, 2014
Pages
Advertisement
Dr. Sevil Yaşar and Dr. Behnam Sabayan